Skip to main content
. 2018 Apr 26;57(8):1390–1399. doi: 10.1093/rheumatology/key104

Fig. 4.

Fig. 4

Relationship between SPARCC SI joint and spine remission in patients achieving ASDAS ID at week 12

(A) SPARCC SI joint remission and (B) SPARCC spine remission. *P < 0.05 vs not achieving remission using Fisher’s exact test for any endpoint in the pooled 5 and 10 mg BID group. BID: twice daily; ID: inactive disease; MIC: minimally important change; n: number of patients achieving/not achieving MIC; SPARCC: SPondyloArthritis Research Consortium of Canada.